Sanjeev Redkar

1.6k total citations
29 papers, 1.0k citations indexed

About

Sanjeev Redkar is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Sanjeev Redkar has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Sanjeev Redkar's work include Epigenetics and DNA Methylation (12 papers), Cancer Mechanisms and Therapy (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). Sanjeev Redkar is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Cancer Mechanisms and Therapy (5 papers) and Hemoglobinopathies and Related Disorders (4 papers). Sanjeev Redkar collaborates with scholars based in United States, United Kingdom and India. Sanjeev Redkar's co-authors include Varsha Gandhi, Lisa S. Chen, David J. Bearss, Pietro Taverna, Peter A. Jones, Christine B. Yoo, William G. Wierda, Jörge E. Cortes, Chunlin Tang and Pasit Phiasivongsa and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sanjeev Redkar

29 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjeev Redkar United States 14 673 368 251 197 121 29 1.0k
Lisa S. Chen United States 15 458 0.7× 518 1.4× 294 1.2× 185 0.9× 123 1.0× 32 911
Anatol Oleksijew United States 15 634 0.9× 123 0.3× 339 1.4× 159 0.8× 86 0.7× 22 1.0k
Juraj Bodo United States 17 665 1.0× 406 1.1× 354 1.4× 252 1.3× 60 0.5× 48 1.3k
Ramesh Jayaraman Singapore 15 433 0.6× 143 0.4× 352 1.4× 253 1.3× 114 0.9× 18 898
Paweł Robak Poland 19 539 0.8× 269 0.7× 372 1.5× 410 2.1× 52 0.4× 86 1.1k
Michele S. Redell United States 18 562 0.8× 100 0.3× 402 1.6× 315 1.6× 70 0.6× 50 1.1k
Masanori Umeda Japan 15 275 0.4× 139 0.4× 145 0.6× 113 0.6× 46 0.4× 59 533
Andrew G. Bosanquet United Kingdom 18 382 0.6× 241 0.7× 303 1.2× 164 0.8× 51 0.4× 45 974
Zhenghong Peng United States 15 526 0.8× 71 0.2× 238 0.9× 265 1.3× 114 0.9× 38 1.0k
Benjamin P. Martin United States 15 716 1.1× 55 0.1× 269 1.1× 204 1.0× 109 0.9× 19 989

Countries citing papers authored by Sanjeev Redkar

Since Specialization
Citations

This map shows the geographic impact of Sanjeev Redkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeev Redkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeev Redkar more than expected).

Fields of papers citing papers by Sanjeev Redkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjeev Redkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeev Redkar. The network helps show where Sanjeev Redkar may publish in the future.

Co-authorship network of co-authors of Sanjeev Redkar

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjeev Redkar. A scholar is included among the top collaborators of Sanjeev Redkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjeev Redkar. Sanjeev Redkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferlita, Alessandro La, Mufaddal Kazi, Vikas Ostwal, et al.. (2025). Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research. 31(7). 1359–1373. 4 indexed citations
2.
Li, Yingchun, Xiquan Zhang, Xin Tian, et al.. (2018). Abstract A200: CBT-502 (TQB2450), a novel anti-PD-L1 antibody, demonstrates favorable activity in MC-38/H-11 murine colon and A375 human melanoma animal models. Molecular Cancer Therapeutics. 17(1_Supplement). A200–A200. 7 indexed citations
3.
Zhong, Boyu, et al.. (2017). Abstract 2096: Bozitinib, a highly selective inhibitor of cMet, demonstrates robust activity in gastric, lung, hepatic and pancreatic in vivo models. Cancer Research. 77(13_Supplement). 2096–2096. 11 indexed citations
4.
Mita, Monica, Michael S. Gordon, Lee S. Rosen, et al.. (2014). Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 74(1). 195–204. 25 indexed citations
5.
Ferraris, Dana, Bridget Duvall, Greg Delahanty, et al.. (2014). Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine Deaminase. Journal of Medicinal Chemistry. 57(6). 2582–2588. 45 indexed citations
6.
Zaman, Shadia, Shujun Shentu, Kumudha Balakrishnan, et al.. (2013). Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines. Journal of Hematology & Oncology. 6(1). 110–110. 16 indexed citations
7.
Gamage, Swarna A., Darby G. Brooke, Sanjeev Redkar, et al.. (2013). Structure–activity relationships for 4-anilinoquinoline derivatives as inhibitors of the DNA methyltransferase enzyme DNMT1. Bioorganic & Medicinal Chemistry. 21(11). 3147–3153. 11 indexed citations
8.
Griffiths, Elizabeth A., Gavin Choy, Sanjeev Redkar, et al.. (2013). SGI-110. DNA methyltransferase inhibitor, Oncolytic. Drugs of the Future. 38(8). 535–535. 2 indexed citations
9.
Griffiths, Elizabeth A., Gavin Choy, Sanjeev Redkar, et al.. (2013). SGI-110. DNA methyltransferase inhibitor, Oncolytic. Drugs of the Future. 38(8). 535–535. 54 indexed citations
10.
Choy, Gavin, et al.. (2012). Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers. Cancer Chemotherapy and Pharmacology. 70(1). 183–190. 6 indexed citations
11.
Tibes, Raoul, Gavin Choy, Sanjeev Redkar, et al.. (2012). A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(2). 463–471. 25 indexed citations
12.
Baxter, Patricia, Patrick A. Thompson, Brian Gibson, et al.. (2010). Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemotherapy and Pharmacology. 67(4). 809–812. 5 indexed citations
13.
Lavelle, Donald, Yogen Saunthararajah, Kestis Vaitkus, et al.. (2010). S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis). Journal of Translational Medicine. 8(1). 92–92. 23 indexed citations
14.
15.
Tang, Chunlin, et al.. (2009). Abstract B209: A self-emulsifying lipid suspension formulation enhances oral bioavailability of MP-470 in a randomized two-way crossover study in healthy male subjects. Molecular Cancer Therapeutics. 8(12_Supplement). B209–B209. 2 indexed citations
16.
Mumenthaler, Shannon M., Amanda Hodge, David J. Bearss, et al.. (2009). Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Molecular Cancer Therapeutics. 8(10). 2882–2893. 98 indexed citations
17.
Chen, Lisa S., William G. Wierda, Sanjeev Redkar, David J. Bearss, & Varsha Gandhi. (2008). Pim Kinase Inhibitor, SGI-1776, Induces Apoptosis in CLL Lymphocytes. Blood. 112(11). 4199–4199. 3 indexed citations
18.
Lavelle, Donald, Kestis Vaitkus, Sanjeev Redkar, et al.. (2007). Oral decitabine reactivates expression of the methylated γ‐globin gene in Papio anubis. American Journal of Hematology. 82(11). 981–985. 28 indexed citations
19.
Mahalingam, Ravichandran, Harish B. Ravivarapu, Sanjeev Redkar, Xiaoling Li, & Bhaskara Jasti. (2007). Transbuccal delivery of 5-Aza-2′-deoxycytidine: Effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech. 8(3). E28–E33. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa S. Chen Breakdown of academic impact, for papers by Anatol Oleksijew Breakdown of academic impact, for papers by Juraj Bodo Breakdown of academic impact, for papers by Ramesh Jayaraman Breakdown of academic impact, for papers by Paweł Robak Breakdown of academic impact, for papers by Michele S. Redell Breakdown of academic impact, for papers by Masanori Umeda Breakdown of academic impact, for papers by Andrew G. Bosanquet Breakdown of academic impact, for papers by Zhenghong Peng Breakdown of academic impact, for papers by Benjamin P. Martin
Rankless by CCL
2026